TNF and irritable bowel syndrome: The degree of severity of symptoms remained unchanged after therapy with the combination of RAF of Abs to S 100, Abs to TNF-α and Abs to H in 365 patients (6.18%) with IBS; in 1 patient (0.02%), a switch to a more “severe” group was observed.